NRG Energy just dropped over 10%—but is it panic time or a rare buying opportunity? In this episode of Am I Catching a Falling Knife?, Dave breaks down the brutal investor reaction to NRG’s underwhelming data center deals, crunches the numbers on revenue impact, and reveals custom buy levels that could be game-changers.📉 Is this a falling knife or a misunderstood power play? Tune in and decide.👉 Like, subscribe, and hit the bell so you don’t miss the next deep dive into meme stocks, market drama, and financial truth.#NRGStock #FallingKnife #StockAnalysis #DataCenterDeals #NRGEnergy #FinancePodcast #StockMarketCrash #BuyTheDip

Hims & Hers Health (HIMS) just got wrecked after missing Q2 revenue and triggering major concerns around its GLP-1 weight-loss pipeline. Is this a rare buying opportunity—or a regulatory disaster in disguise?

Join Dave on "Am I Catching a Falling Knife?" as we deep dive into:

👉 Market narrative vs fundamentals

👉 DCF and PEG valuation models

👉 Buy zones for risk-tolerant traders

This episode blends sharp satire with serious data so you can navigate volatility with confidence. Not financial advice—just financial comedy.

#HIMS #stocks #fallingknife #GLP1 #telehealth #stockmarket #financememes

ON Semiconductor just dropped over 20%—but is it really a falling knife, or a deep-value play in disguise?In this episode of *Am I Catching a Falling Knife?*, host Dave cuts through the hype and dives deep into ON’s latest earnings, sector pressures, and hidden opportunities. With sharp DCF models and PEG-based reality checks, we expose the wild gap between ON’s current price and its intrinsic value.*Not financial advice. But definitely financial entertainment.*👇 Sound off in the comments. Would you catch this knife?#StockAnalysis #SemiconductorStocks #ONStock #ValueInvesting #MemeFinance #FallingKnife

Coinbase just dropped nearly 24% — but is this the moment to buy the dip or avoid a deeper dive? In this episode of **Am I Catching a Falling Knife?**, we break down the numbers behind COIN’s Q2 earnings, analyze key revenue segments, and run a narrative-adjusted DCF model to find out if this knife is worth catching.With retail traders pulling back and Coinbase doubling down on institutions, is this the pivot that changes everything?🔔 Subscribe for more hard-hitting analysis, meme stock autopsies, and big-brain breakdowns of market chaos.Disclaimer: Not financial advice. But you already knew that.#stockanalysis #stockmarketcrash #coinbase

Eastman Chemical (EMN) nosedived 24.41% after missing earnings and slashing forecasts. But is the panic warranted—or is Wall Street ignoring a potential rebound?In this episode of Am I Catching a Falling Knife?, Dave unpacks EMN’s business breakdown, the macro threats from trade policy, and a stormy balance sheet with $5.13B in debt and negative cash flow.Get the full analysis—from earnings stumbles to segment-by-segment damage control.📌 Subscribe for deep-dive market dissections with just enough satire to stay sane.⚠️ This isn’t financial advice—just finance entertainment, Dave-style.#stockanalysis #marketdip #stockcrash

Accenture (ACN) just hit a 52-week low after a 9.69% drop—despite posting strong earnings and boosting its 2025 outlook. So what’s going on under the hood?In this episode of Am I Catching a Falling Knife?, Dave breaks down the market panic around new bookings, the ripple effect on earnings, and crunches two valuation models (DCF vs. PEG) to help you decide: bargain or blunder?🎧 Like, Subscribe & Hit That Bell so you never miss a market deep dive.📢 Disclaimer: This video is for entertainment and informational purposes only. Not financial advice.#stockanalysis #accenture #ACN stock

Cigna (CI) just took a scalpel to its chart—down 10% in ten days. But is this healthcare heavyweight bleeding out or quietly prepping for a rebound surgery? 💉In this episode of Am I Catching a Falling Knife?, Dave breaks down:🔍 The root causes of CI’s drop — specialty drug costs, regulatory pressure, and retention struggles 📉 Our estimate: a potential 11% quarterly earnings hit 💰 DCF vs PEG valuation — does CI still hold long-term value? 📊 Three custom buy levels you won't find in mainstream coverage 🏥 The role of Evernorth and Cigna Healthcare in this unfolding narrativeThis is NOT financial advice—just one man's dive into a stock with sharp edges and hidden strength.➡️ Subscribe for more sharp takes, satirical breakdowns, and bold plays in the market jungle.#Cigna #CIstock #StockMarketCrash #FinanceSatire #FallingKnifePodcast

Align Technology (ALGN) just fell off#stockanalysis a cliff—down 32.90% in ten days, and we’re breaking down why. In this episode of "Am I Catching a Falling Knife?", Dave unpacks ALGN’s brutal earnings report, forecasts a 36% hit to quarterly profits, and reveals three bold buy-levels you won’t want to miss.💸 Is this an elite business on sale or a value trap wrapped in orthodontic veneers?✅ DCF vs PEG: Which valuation method holds up? 🔍 Analyst downgrades, macro headwinds, and restructuring fallout 🦷 Invisalign’s role in ALGN’s revenue mixThis is NOT financial advice—just one man's dive into a fallen stock with sharp edges.Subscribe for more deep dives into volatile plays, satirical breakdowns, and surprising opportunities in the market jungle.#stockanalysis #stockmarketcrash #stocks

The digital payments giant PayPal ($PYPL) is under pressure. Despite solid earnings and raised guidance, market fears about competition and declining engagement are crushing the stock price. In this episode of ‘Am I Catching a Falling Knife?’, host Dave slices through the noise with sharp analysis, a clean DCF breakdown, and valuation insights that could help you decide: is PayPal a comeback story or a cut waiting to happen?This isn’t financial advice—just one investor’s take. Subscribe for more stock dissections each week.#PYPL #PaypalStock #StockMarket #Investing #FallingKnife #DCF #StockAnalysis

📉 UPS has taken a sharp tumble—down 8.73%, missing profits, and holding back full-year guidance... again. But is this just macro panic, or a golden entry point for long-term investors?

In this episode of *Am I Catching a Falling Knife?*, we break down UPS's core business, analyze their earnings miss, and run the numbers—from DCF to PEG—to find potential buy zones. Is $76.16 fair value, or is $30.00 where the real reward lies?

🚚 Featuring: Macroeconomic chaos, logistics math, and a company too big to ignore.

✅ Like, Subscribe, & Share if you want more sharp takes and smart valuations.

📺 New episodes weekly. Keep those portfolios sharp!

#UPS #StockCrash #Investing #StockMarket #FinancePodcast #FallingKnife #ValuationModel